MIRAGEN THERAPEUTICS INC - COM (MGEN)

CUSIP: 60463E103

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM
Total 13F shares
11,061,562
Share change
-220,552
Total reported value
$61,704,366
Price per share
$5.58
Number of holders
56
Value change
-$1,687,318
Number of buys
27
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 60463E103?
CUSIP 60463E103 identifies MGEN - MIRAGEN THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MIRAGEN THERAPEUTICS INC - COM (MGEN) as of Q3 2018

As of 30 Sep 2018, MIRAGEN THERAPEUTICS INC - COM (MGEN) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,061,562 shares. The largest 10 holders included FMR LLC, BlackRock Inc., Opaleye Management Inc., Vanguard Group Inc, Artal Group S.A., STATE STREET CORP, JPMORGAN CHASE & CO, Point72 Asset Management, L.P., NORTHERN TRUST CORP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 56 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.